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Definition and Etiology of Preeclampsia
Preeclampsia is a human pregnancy-specific disorder
that is diagnosed by the new appearance of hyperten-
sion and proteinuria after 20 weeks’ gestation [1]. The
incidence of preeclampsia is between 2% and 10% 
of pregnancies, depending on the definition used and
population studied [2–5]. It is a leading cause of 
perinatal morbidity and mortality, and the only inter-
vention that effectively reverses the syndrome is deliv-
ery. Consequently, a large proportion of the perinatal 
morbidity is due to iatrogenic prematurity. It is esti-
mated that up to 15% of preterm births are secondary
to delivery for preeclampsia [6].
The cause of preeclampsia is still unknown. A com-
pletely satisfactory, unifying hypothesis has not emerged.
There may be several underlying predispositions with
effects that result in the common group of signs and
symptoms. In 1989, Roberts et al formally proposed
that maternal endothelial cell dysfunction is the key
event resulting in the diverse clinical manifestations of
preeclampsia [7]. Endothelial cell dysfunction or acti-
vation is a term used to define an altered state of endo-
thelial cell differentiation, typically induced as a result of
cytokine stimulation. Evidence has since accumulated
to support a major role for endothelial dysfunction,
including vasospasm and increased vascular reactivity,
as the final common pathway of several different patho-
physiologic mechanisms in preeclampsia [8–10].
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SUMMARY
Preeclampsia is a human pregnancy-specific disorder that is diagnosed by the new appearance of hypertension
and proteinuria after 20 weeks’ gestation. It is a leading cause of perinatal morbidity and mortality, and the
only intervention that effectively reverses the syndrome is delivery. Oxidative stress of the placenta is considered
to be a key intermediary step in the pathogenesis of preeclampsia, but the cause for the stress remains unknown.
Hypoxia-reoxygenation (H/R) injury, as a result of intermittent placental perfusion secondary to deficient tro-
phoblast invasion of the endometrial arteries, is a possible mechanism. In this review, we present evidence to
show that there is a plausible basis from which to assume that blood flow in the intervillous space will be inter-
mittent in all normal pregnancies. The intermittency will be exacerbated by impaired conversion of the spiral
arteries, or by the presence of atherotic changes that reduce their caliber as seen in preeclampsia. Placental
oxidative stress can be the consequences of fluctuations in oxygen concentrations after H/R through the actions
of reactive oxygen species. On this basis, there will be a complete spectrum of placental changes among the nor-
mal, the late onset and the early onset preeclamptic states. Viewing the syndrome as a continuum of H/R insults
provides new insight into the pathophysiology of pregnancy that will hopefully lead to improved clinical inter-
ventions. [Taiwanese J Obstet Gynecol 2006;45(3):189–200]
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Recently, the hypothesis has been extended in two
ways. First, it has been proposed that some women
are more sensitive to endothelial dysfunction or have
preexisting endothelial dysfunction associated with a
long-term tendency to diseases such as hypertension,
diabetes or collagen vascular diseases [11]. This gives
a clear explanation of the long-known association
between these medical conditions and preeclampsia.
Second, it has been suggested that endothelial dys-
function is one aspect of a generalized systemic mater-
nal inflammatory response that also affects circulating
leukocytes [12,13]. In other words, preeclampsia is
not a separate condition but simply the extreme end of
a range of maternal systemic inflammatory response
engendered by pregnancy itself. This continuum theory
of preeclampsia implies that any factor that increases
the maternal systemic inflammatory response to preg-
nancy will predispose to preeclampsia [14,15].
Role of Placenta in Preeclampsia
So, what feature of pregnancy results in the profound
and reversible alteration of maternal physiologic func-
tions such as the inflammatory response and endo-
thelial activation that are characteristic of the
preeclampsia syndrome? Diverse evidence shows that
the placenta serves as the centerpiece in the patho-
genesis of preeclampsia. Preeclampsia can occur with
hydatidiform moles, suggesting that the presence of 
a fetus is not strictly necessary [16,17]. A distended
uterus is probably not required as preeclampsia may
develop in abdominal pregnancies in which the uterus
is minimally enlarged [18,19]. Moreover, the clinical
signs and lesions of preeclampsia remit within days
after termination of pregnancy [20].
If we accept that the placenta is where the disease
originates, then this is where we should initially look
for evidence of pathologic changes. The most widely
recognized predisposing factor for preeclampsia is poor
placentation, revealed as insufficient cytotrophoblast
invasion and defective remodeling of the maternal 
spiral arteries.
Poor placentation in preeclampsia
During the early stages of normal pregnancy, the
cytotrophoblasts invade the uterine spiral arteries and
progressively displace the vascular endothelial cells. By
the end of the second trimester, these vessels have lost
their muscular and elastic components that have been
replaced by a fibrinoid layer of variable thickness in
which trophoblastic cells are embedded. As a result,
the spiral arteries are transformed into flaccid tubes
with a diameter at least four times greater than that of
nonpregnant vessels, thus providing a low resistance
circuit to the intervillous space. Furthermore, the loss
of vascular wall components renders the altered ves-
sels unresponsive to vasoreactive stimuli. This process
of vascular transformation or remodeling is thought to
involve virtually all the 100–150 spiral arteries in the
placental bed, and extends as far as the inner third of
the myometrium [21].
In contrast, morphologic examinations of placen-
tal bed biopsies from women with preeclampsia show
that such physiologic changes are restricted, being lim-
ited to the superficial region of the endometrium or
being absent altogether [22–24]. As a result, the mean
external diameters of the spiral arteries in women with
preeclampsia are less than half of the diameters of
similar vessels from uncomplicated pregnancies. It is
to be expected that placental perfusion would be
reduced in the context of the spiral artery pathology
just described. This is confirmed by Doppler ultra-
sound assessment of blood flow velocimetry in the
uterine arteries [25] and foci of placental infarction in
women with preeclampsia [26]. Moreover, surgical
reduction of the blood supply to the uterus or placenta
in several animal experiments induces a hypertensive
state that resembles hypertension in human preg-
nancy, suggesting a possible relationship between pla-
cental ischemia and preeclampsia [27]. Accordingly, a
consensus has gradually emerged that the placental
lesions associated with preeclampsia arise from a state
of chronic hypoxia.
Evidence Against Chronic Placental
Hypoxia in Preeclampsia
However, a survey of the impact of oxygen on placen-
tal development and structure indicates that the con-
cept of chronic placental hypoxia in preeclampsia may
be overly simplistic for a number of reasons. Firstly,
hypoxia refers to relatively low oxygen supply with res-
pect to tissue metabolic demand, either as a result of
an abnormal inspired oxygen or inadequate blood
supply. For instance, a moderate chronic restriction of
uterine blood flow (30% reduction in the last one-third
of gestation) in sheep results in a significant reduction
in fetal and placental weights [28]. However, examina-
tion of placental metabolism in preeclampsia shows
that there is no reduction in energy supplies as would
be expected if there were indeed chronic hypoxia [29].
Similarly, in many cases of preeclampsia, birth and 
placental weights are within the normal range. A 
large-scale retrospective cohort study even shows that
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there is a significant association of preeclampsia with
large-for-gestational-age infants [30]. Secondly, not
all preeclamptic placentas are associated with utero-
placental vascular pathology, and equally the same
vascular pathologies may occur in other complications
of pregnancy, such as premature delivery and pre-
mature rupture of membranes [31,32]. Meekins et al
found that endovascular trophoblast does not show
an all-or-none invasive phenomenon in normal and
preeclamptic pregnancies. Instead, there is a gradient
of decrease in the percentage of decidual and myo-
metrial arteries invaded from normal pregnancy to
preeclampsia [23]. The linkage between poor placen-
tation and the development of preeclampsia is not
absolute, so other factors must be operating. Thirdly,
despite the numerous claims of placental hypoxia in
preeclampsia, no direct measurements of dissolved
oxygen tension within the intervillous space have been
performed in vivo to confirm that this is the case. In
contrast, pregnancy at high altitude is one condition
where it is known that the oxygen tension of the mater-
nal arterial supply to the placenta is significantly
reduced [33]. Examination of placentas from uncom-
plicated pregnancies at high altitude shows that the
organ is remarkably normal, and does not show an
increased level of infarction [34]. It would appear,
therefore, that a reduced oxygen tension per se does not
cause the lesion most characteristically associated with
preeclampsia. Finally, it is now widely accepted that
there are major changes in maternal blood flow to the
placenta at the end of the first trimester [35]. As a
result, the oxygen tension rises sharply at 10–12 weeks’
gestation. Before then, the trophoblast and other tis-
sues have been proliferating and functioning very ade-
quately at low oxygen concentrations, concentrations
that are far lower than those compatible with fetal sur-
vival in later pregnancy. The trophoblast is therefore
well adapted to low oxygen concentrations.
Consequently, it would appear that the absolute
oxygen concentration existing in the intervillous space
is not of paramount importance. But then what other
features of the intervillous circulation can explain the
placental pathology in preeclampsia? Recent observa-
tions from the first trimester explant culture show that
placental tissues thrive in low oxygen concentrations
but become stressed, as indicated by rapid degenera-
tion of the syncytium, when the oxygen tension rises
[36]. This suggests that changes in oxygen concentra-
tion are more important to trophoblast wellbeing 
than simply the absolute tension prevailing at the
time. This idea leads to the development of the con-
cept that fluctuations in oxygen concentrations result-
ing from intermittent perfusion within the intervillous
space might be the trigger for the placental changes
seen in preeclampsia.
Intermittent Perfusion of the Human
Placenta In Vivo
Although decisive proof showing that perfusion of the
intervillous space in human pregnancy can be intermit-
tent is unavailable at present, studies of the rhesus
monkey, a species in which the uterine vasculature and
form of placentation is very similar to that of the human,
show that this might be the case. Martin et al used
repeated radioarteriographic placentograms to study
the contribution of individual spiral arteries to inter-
villous space blood flow during uterine relaxation on
rhesus monkeys at various stages of pregnancy [37].
By monitoring the positions of the arterial spurts into
the intervillous space in successive films, the patency of
individual spiral arteries was assessed. The proportion
of arterial entries showing intermittency varied between
animals, and the proportion of vessels demonstrating
this behavior did not vary with gestational age. Even
vessels that did not undergo complete closure showed
variations in the size of their spurts between successive
films. As the spurts appeared or disappeared independ-
ent of recorded myometrial activity, the authors con-
cluded that this variability in blood flow was most likely
the result of vasoconstriction in individual arterial walls,
rather than of external compression of the vessels.
There is no doubt that external compression of the
spiral arteries does occur during uterine contractions
in the rhesus monkey [38,39]. Comparable experiments
have also been performed on women at midgestation
for therapeutic abortion and at term with malformed
fetuses for termination to observe the effects of uterine
contractions on the uteroplacental blood flow [40].
Although the uterine contractions in these studies were
induced by nonphysiologic methods, similar effects,
though to a lesser degree, occurred after Braxton–Hicks
contractions in normal pregnancy.
Therefore, it seems highly likely that fluctuations in
intervillous blood flow occur during normal human preg-
nancies, and that these can be on a regional or a more
global basis. They probably increase in severity toward
the end of gestation as uterine contractions become
stronger and more frequent, culminating with delivery.
It also seems reasonable to assume that periodic vaso-
constriction may be more common in preeclampsia
due to the retention of smooth muscle within the
endometrial segments of the spiral arteries. The associ-
ated reduced or absent dilatation of the proximal end
of the spiral arteries would restrict flow still further.
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Impact on placental oxygenation
If the spiral arteries are intermittent in their function-
ing, then what might be the impact of this phenome-
non on placental oxygenation? In the human organ,
and that of the rhesus monkey, it is well established
that each spiral artery delivers its oxygenated blood
into the center of a placental lobule [41]. The blood
then drains peripherally, exchanging with the fetal cir-
culation as it does so. Because of the dense meshwork
of villi, it is unlikely that supply from an adjacent spiral
artery would be able to compensate for a transient
reduction in arterial inflow into an individual lobule.
Therefore, during the period of absent or reduced arte-
rial inflow, the oxygen tension will decrease within the
affected lobule. Oxygen will continue to be extracted
from the intervillous space by the trophoblast, which is
metabolically highly active and accounts for approxi-
mately 40% of oxygen consumption by the fetoplacental
unit [42] and by the fetus. When the maternal arterial
inflow to the lobule is restored, the local oxygen ten-
sion will rise sharply. Such fluctuations in oxygen ten-
sion could provide the basis for an ischemia-reperfusion
(hypoxia-reoxygenation [H/R]) type injury, the effects
of which are well documented in other organ systems
such as the heart, brain and intestine.
H/R Injury
The detrimental effects of H/R arise mainly from its
ability to generate high concentrations of free radicals
[43]. A free radical is defined as any species that can
exist independently and contains one or more unpaired
electrons [44]. Examples include superoxide, nitric oxide
(NO) and hydroxyl radicals. Most free radicals in biol-
ogy fit within the broader category of reactive oxygen
species (ROS), which includes oxygen-containing radi-
cals, and nonradical but reactive molecules derived
from oxygen, such as hydrogen peroxide and peroxyni-
trite anion [44].
Generation of ROS in H/R
ROS can be produced at several sites, but the two prin-
cipal sources as far as H/R is concerned are the elec-
tron leakage from the respiratory chain in mitochondria
and the xanthine dehydrogenase/xanthine oxidase
(XDH/XO) system. Under normal aerobic conditions,
electrons are shuttled along the enzyme respiratory
chain on the inner membrane of mitochondria until they
are passed on to molecular oxygen, building in turn 
the proton gradient in the intermembrane space, which
drives adenosine triphosphate (ATP) synthesis [44].
The mitochondrial enzymes do not function perfectly,
however, and inevitably a small number of electrons
will leak on to oxygen to form superoxide radicals.
During the hypoxic period, there is little or no molecu-
lar oxygen available to act as the final recipient, and so
electrons build up on the respiratory chain. Rather
paradoxically, this accumulation leads to increased
superoxide formation as it causes increased leakage on
to whatever oxygen is around. However, if oxygen is
reintroduced before cellular function has been com-
promised too far, then a much greater burst of super-
oxide radical formation takes place, as there is suddenly
more oxygen available for the electrons accumulated on
the respiratory chain to leak on to [45,46].
The second, and probably more major, source of
superoxide radicals in H/R is through the transforma-
tion of XDH to XO [47]. Usually, this enzyme is present
as the holoenzyme XDH/XO. XDH converts purines to
uric acid with the reduction of nicotinamide adenine
dinucleotide (NAD) to reduced NAD (NADH), while
XO metabolizes xanthine and hypoxanthine to uric
acid, using oxygen as the electron recipient, with the
production of superoxide radicals. With hypoxia and
in response to several cytokines, XDH/XO synthesis
increases, and conversion of the enzyme to the XO
form is enhanced. Meanwhile, during the hypoxic
period, the substrate hypoxanthine builds up due to
breakdown of ATP. So when oxygen is reintroduced, a
burst of superoxide radicals is generated.
Damaging effects of oxidative stress in H/R
The accumulation of superoxide that occurs after H/R
allows for an enhanced generation of other ROS, there-
fore exerting a broad spectrum of cytotoxicity [48]. A
diverse array of cellular and extracellular fluid antioxi-
dants has evolved to control and compartmentalize,
but not necessarily eliminate, the production of ROS
[48]. However, under particular circumstances such as
an insult of H/R, the generation of ROS exceeds the
capacity of the antioxidant defenses, so oxidative stress
results. Not only do they behave as simple reactants
that peroxidize membrane lipids, oxidize DNA or dena-
ture enzyme proteins, ROS generated by H/R are now
recognized as interacting with physiologic signal trans-
ducers [49–51]. But, when present at high and/or 
sustained levels, ROS can cause cellular dysfunction,
growth arrest or ultimately cell death.
Although the mechanisms of cell death in H/R injury
have not been fully understood, recent studies indicate
that dysregulation of calcium (Ca2+) metabolism and
formation of the mitochondrial permeability transition
pore (PTP) are key intermediary events [52–54]. ROS
originating from H/R can damage the endoplasmic
reticulum Ca2+-uptake system and interfere with Ca2+
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efflux through the plasma membrane, therefore increas-
ing the levels of intracellular free Ca2+ [52] and sub-
sequently leading to the formation of PTP [53,55,56].
As a result of PTP opening, the mitochondrial mem-
brane potential collapses, leading to the loss of ATP
synthesis. If mitochondria throughout the cell are
affected, then ATP concentrations fall precipitously,
ionic homeostasis is lost and the cell undergoes pri-
mary necrosis [54,57]. Involvement of a more limited
number of organelles or transient opening of the PTP
may allow ATP to be maintained at levels sufficient to 
permit apoptosis to occur instead [58].
The damaging effects of H/R can be more profound
and global. One of the most significant consequences
is the development of microvascular dysfunction within
the organ experiencing H/R [59]. Under normal condi-
tions, the flux of NO in endothelial cells greatly exceeds
the rate of superoxide formation. However, within min-
utes after reoxygenation, the balance between NO and
superoxide is tipped in favor of superoxide. This imbal-
ance results from a sudden increase in the production
of superoxide by endothelial cells and a corresponding
decline in the synthesis of NO from endothelial NO
synthesis. The relatively low levels of bioactive NO
reduce its effectiveness to oppose leukocyte- or platelet-
endothelial cell interactions or to serve as the second-
ary messenger when certain endogenous vasodilators
such as acetylcholine interact with their endothelial
receptors.
The resultant ROS after H/R can rapidly initiate or
exacerbate the inflammatory state in endothelial cells
by eliciting the production of leukotriene B4 and platelet-
activating factor (PAF). ROS can also help to sustain
the neutrophil–endothelial cell adhesion that occurs
several hours after reoxygenation by activating genes
that encode adhesion molecules such as E-selectin
(sustains leukocyte rolling) and intercellular adhesion
molecule-1 (ICAM-1; sustains firm adhesion and emi-
gration of leukocytes). Besides, neutrophils infiltrated
within the microvasculature following reperfusion can
further lead to local tissue injury [60].
Another devastating consequence of H/R injury is
the development of damage in organs not involved in
the initial hypoxia insult, known as the systemic inflam-
matory response syndrome and multiple organ dysfunc-
tion syndrome if multiple organ failure occurs [59,61].
Several mechanisms have been proposed to explain the
remote organ injury induced by H/R; however, most
attention has focused on the role of inflammatory
mediators [61]. Indeed, ample evidence shows that
postischemic tissues generate and release inflammatory
mediators such as tumor necrosis factor-α (TNF-α) and
PAF that can activate and attract circulating neutrophils,
induce generalized neutrophil and endothelial adhesion
molecule expression and enhance the opportunities for
neutrophil–endothelial cell interaction at remote sites.
Evidence of H/R Effects in the Placenta
The human placenta is of the hemochorial type and
consists of an extensively branched fetal villous tree
that is bathed by the maternal blood circulating in 
the intervillous space. The contact surface between
fetal placental tissues and maternal blood is the syn-
cytiotrophoblast, which acts as the endothelium for
the intervillous space. Therefore, similar consequences
and mechanisms of H/R injury just described can be
expected to occur within the placenta. So, if we
assume that intermittent blood flow to the intervillous
space can lead to fluctuations in oxygen concentra-
tions, and such alterations in oxygenation can further
cause H/R injury, then the placenta must have the 
necessary machinery to generate H/R insults. Further-
more, there should be evidence showing footprints of
H/R injury in the placenta, particularly in the preeclamp-
tic placenta. Indeed, from reviewing the evidence, it
would appear that the human placenta is subjected to
H/R injury, and there are several lines of evidence sig-
naling the effects of H/R injury on the placenta in nor-
mal and preeclamptic pregnancies.
XDH/XO in the placenta
XDH/XO messenger ribonucleic acid (mRNA) and
enzyme activity have been demonstrated in term human
placenta [62]. Furthermore, the relative activity of XO
to the total XDH/XO activity, an index of conversion of
XDH/XO to XO, was found to be considerably higher
in the placentas of laboring women [63]. Labor is
clearly associated with intermittency of intervillous
blood flow and, therefore, fluctuating oxygen tensions.
In addition, women in labor have higher blood levels
of hypoxanthine than women not in labor, and ele-
vated levels of hypoxanthine are observed in the uter-
ine vein relative to peripheral blood in women during
labor, indicating that the uteroplacental unit is the
major source [64].
In parallel with observations in women who are in
labor, studies on preeclamptic placentas show increased
immunostaining of XDH/XO in the floating and anchor-
ing villi as compared to that of normal placentas [65].
The staining is mainly in the villous endothelium and
trophoblast. Especially noteworthy is that these cellular
components are immunohistochemically co-localized
with nitrotyrosine residues, a marker for peroxynitrite
formation and oxidative stress [65]. Enzyme activity
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assays on placental bed currettings also showed that
both XDH/XO and XO activities were increased in pla-
centas from preeclamptic pregnancies compared with
normal controls. Furthermore, circulating uric acid
levels are known to be increased in patients with pre-
eclampsia [66]. Uric acid is a by-product of the
XDH/XO pathway, which is activated by H/R. So, it is
likely that the elevation of uric acid in preeclampsia is
a result of H/R and XO stimulation.
Mitochondria as a possible source of placental
oxidative stress
Normally, superoxide concentration in the mitochon-
dria is tightly controlled by manganese superoxide dis-
mutase (MnSOD) in the mitochondria and by copper/
zinc isoform (Cu/ZnSOD) in the cytosol [48]. How-
ever, as mentioned earlier, a burst of superoxide anions
is generated when oxygen is reintroduced to hypoxic
cells. This may overwhelm local antioxidant defense and
lead to oxidative stress.
In preeclamptic placentas, the mitochondria also
show swelling with a loss of cristae. Indeed, placental
mitochondria have been suggested as a source of
oxidative stress in preeclampsia. Studies on isolated
mitochondria show that not only the levels of lipid
peroxide, as estimated by malondialdehyde, but also
the potential for lipid peroxidation is greater in the
mitochondria fraction from preeclamptic placentas
than in the mitochondria fraction from normal placen-
tas [67]. It is also known that superoxide is the radical
responsible for mitochondrial lipid peroxidation in this
system.
Can H/R Injury be a Possible Etiologic
Factor for Preeclampsia?
There is no doubt that all the conditions necessary for
H/R injury seems to be met within the human placenta;
however, a systematic study on the causal relationship
between H/R and placental changes in preeclampsia has
not yet been performed. Can H/R injury be a possible
etiologic factor for preeclampsia? There are several fea-
tures that characterize the preeclamptic placenta and
that may be important in the generation of the mater-
nal syndrome. These include increased placental oxida-
tive stress, increased syncytiotrophoblastic apoptosis
and increased production of proinflammatory cytokines
such as TNF-α. Each of these placental mechanisms has
been the focus of recent investigation. As mentioned
already, evidence from other organ systems or in vitro
experiments shows that these events can be the conse-
quences of H/R through the actions of ROS.
Oxidative stress in the preeclamptic placenta
Epidemiologic evidence shows that several risk factors
for preeclampsia, such as diabetes and obesity, are
identical to those that increase the risk of atheroscle-
rosis [68]. The lipid profile associated with pre-
eclampsia is also associated with atherosclerosis: a low
concentration of high-density lipoprotein cholesterol,
increased concentrations of serum triglycerides and
increased formation of small, dense low-density lipo-
protein particles. In addition, preeclampsia is associ-
ated with a distinct pathologic lesion of the decidual
arterioles known as acute atherosis [69]. Acute athero-
sis bears a striking resemblance to the atherosclerotic
lesions of coronary arteries. These similarities and the
generally accepted role of oxidative stress in athero-
sclerosis lead to the assumption that oxidative stress
plays a pivotal role in the cause of the preeclamptic
syndrome [68,70,71].
Although the cause of oxidative stress remains
unclear, considering the unique role of the placenta in
preeclampsia, it is likely that the placenta is the origin
or major source of oxidative stress observed in the syn-
drome. Several lines of evidence support this assump-
tion, including increased lipid peroxidation products,
increased nitrotyrosine immunostaining and decreased
antioxidant enzyme activities in preeclamptic placentas.
Lipid peroxidation products have been suggested
as candidate factors that may mediate disturbance of 
the maternal vascular endothelium in preeclampsia
[70,71]. Studies of women undergoing cesarean sec-
tion showed significantly higher contents of lipid
hydroperoxides, phospholipids, cholesterol and free 
8-iso-prostaglandin F2α (8-iso-PGF2α), but not the total
(free plus esterified) 8-iso-PGF2α in decidual tissues
from women with preeclampsia as compared with tis-
sues from normal pregnancies [72,73]. Moreover, tissue
levels of free and total 8-iso-PGF2α are significantly
higher in preeclamptic placentas than in normal pla-
centas [74]. Isoprostanes like 8-iso-PGF2α are pro-
duced specifically by free radical-catalyzed peroxidation
of arachidonic acid [75]. Free 8-iso-PGF2α has activi-
ties of relevance to preeclampsia, being a potent vaso-
constrictor in kidney [75] and placenta [76], platelet
activator [77], and inducer of the release of endothelin
from endothelial cells [78].
Increased levels of thromboxane and lipid perox-
ides associated with a decrease in glutathione peroxide
activity have been reported in placentas from pre-
eclamptic patients compared with those from normal
pregnancies [79]. In parallel, in vitro production of
lipid peroxides and thromboxane is increased in 
both trophoblast cells and villous tissues from women
with preeclampsia [80]. Furthermore, production of
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8-iso-PGF2α and malondialdehyde (a lipid peroxide
metabolite), as measured by the levels in the medium,
is higher for preeclamptic placental tissue explants
than for normal tissue explants [74]. These data pro-
vide convincing evidence that oxidative stress and lipid
peroxidation are abnormally increased in the placentas
of preeclamptic women.
The endothelial and inducible isoforms of NO syn-
thase have been characterized in the human placenta
[81,82]. The NO released may play a role in reducing
arteriolar tone, and in preventing platelet and neutrophil
adhesion to the endothelial cells and trophoblast sur-
face. However, within minutes after reoxygenation of
hypoxic tissues, the balance between NO and superox-
ide production is tipped in favor of superoxide as pre-
viously described. Superoxide reacts with NO much
faster than the rate of superoxide dismutation, thus
producing the peroxynitrite anion, which is a strong
and long-lived oxidant [83]. The peroxynitrite anion is
capable of modifying proteins by nitration of tyrosine
residues to form nitrotyrosine. Therefore, the presence
of nitrotyrosine is suggestive of in vivo activity of perox-
ynitrite and, thus, indicates oxidative damage [84].
Nitrotyrosine immunostaining has been detected
around foam cells in human atherosclerotic lesions
[85]. In the placenta, Myatt et al found greater nitroty-
rosine immunostaining in villous vascular endothelium
and its surrounding smooth muscle cells, and in villous
stromal cells in preeclampsia compared to normal preg-
nant controls [86]. Moreover, Many et al found partic-
ularly intense immunoreactivity of nitrotyrosine within
the invasive cytotrophoblasts in placental biopsies and
vascular endothelium in the floating villi obtained from
women with preeclampsia [65]. Together, the findings
of nitrotyrosine residues in these cellular components
of preeclamptic placentas may reflect increased pro-
duction of superoxide in this setting.
Placental generation of ROS in preeclampsia might
be facilitated by a decrease in local antioxidant defense,
although it is not clear whether this reduced antiox-
idant defense is causative or secondary to enhanced
depletion. The activity of placental SOD and glucose
6-phosphate-dehydrogenase is decreased in preeclamp-
sia compared to normal pregnancy [87]. Moreover, the
activity and mRNA expression of Cu/ZnSOD and glu-
tathione peroxidase, and tissue levels of vitamin E are
significantly lower in placental tissues from preeclamp-
sia than from normal pregnancy [88].
In summary, there appears to be an increase in ROS
generation in the placenta of preeclamptic women.
There is evidence for increased nitrotyrosine residue
formation in the preeclamptic placenta suggestive of
peroxynitrite formation, perhaps arising from local
NO production coupled with increased generation of
superoxide anions and either regionally decreased or
inadequate SOD.
Apoptosis in the preeclamptic placenta
Apoptosis is a type of cell death that is accomplished
by specialized cellular machinery, which is often pro-
grammed as a component of normal development 
and differentiation in most tissues, or can be induced
by exogenous stimuli [89]. In the human placenta,
apoptosis has been reported to increase progressively
throughout pregnancy [90] and is suggested to play a
role in the differentiation, syncytial fusion and degen-
eration of villous trophoblasts [91,92]. On the other
hand, increased apoptosis, particularly in the syncy-
tiotrophoblast, has been found in placentas from
pregnancies complicated by preeclampsia compared
with normal pregnancies [93,94]. The increased pla-
cental apoptosis may be a primary pathologic event
or, alternatively, a secondary effect of altered placental
oxygenation in preeclampsia. In this regard, Redman
and Sargent proposed that oxidative stress might stim-
ulate syncytiotrophoblast apoptosis and so increase
shedding of microvillous fragments [14]. The resultant
debris is thought to activate an enhanced systemic
inflammatory response including endothelial cell dys-
function in the mother.
Production of TNF-a in preeclampsia
There is a significant body of evidence suggesting 
that TNF-α plays an important role in the patho-
physiology of preeclampsia [27,70,95–98]. Women
with preeclampsia have higher plasma levels of TNF-α
compared to normal pregnant women, and elevated
levels of TNF-α protein and mRNA have also been
demonstrated in their placentas [99,100]. TNF-α
can activate the endothelial cells and upregulate the
gene expression of numerous molecules such as
platelet-derived growth factor, cell adhesion mole-
cules, endothelin-1 and PAI-1. These molecules have
been reported to have detrimental effects on the vas-
culature and also characterize preeclamptic pregnancy
[101–103]. Furthermore, chronic infusion of TNF-α
into rats during late pregnancy results in a significant
increase in renal vascular resistance and arterial pres-
sure [104,105].
In Vitro H/R as a Model for Placental
Oxidative Stress
In an attempt to investigate the effects of H/R on the
placenta more systematically, we have developed an 
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in vitro model in which villi from normal term placentas
are subjected to a period of hypoxia followed by reoxy-
genation [106]. Abundant ROS are generated rapidly
in the villous endothelium, and to a lesser extent in the
syncytiotrophoblast and stromal cells when hypoxic
villous tissues are reoxygenated in vitro. Furthermore,
the expression of several well-characterized markers 
of oxidative stress including nitrotyrosine residues, 
4-hydroxy-2-nonenal (4-HNE) adducts and inducible heat
shock protein 72 are greatly increased in villous tissues
subjected to H/R compared to the controls main-
tained under constant hypoxia. In contrast, preloading
villous tissues with ROS scavengers such as desferriox-
amine and α-phenyl-N-tert-butylnitrone significantly
reduces the level of oxidative stress in H/R. Moreover,
the patterns of immunostaining of nitrotyrosine residues
and 4-HNE adducts suggest that there are parallels
between the resultant oxidative stress and that observed
in preeclampsia [65,86,107,108].
Further experiments using this model system have
demonstrated that H/R is a potent inducer of the
release of cytochrome c from mitochondria, activation
of caspase 3 and cleavage of poly(ADP-ribose) poly-
merase in villous tissues [109]. These events are associ-
ated with an increased number of syncytiotrophoblastic
nuclei displaying apoptotic changes and increased lac-
tate dehydrogenase release into the medium. The
causal relationship between the generation of ROS
and these apoptotic changes is revealed by the fact
that pre-administration of desferrioxamine attenuates
the insult. These results indicate that H/R is a powerful
stimulus for apoptotic changes within the syncytiotro-
phoblast, another characteristic feature of the pre-
eclamptic placenta and one that has been linked with
generation of the syndrome.
Similarly, in vitro H/R was found to cause increased
placental expression of TNF-α mRNA and production
of TNF-α, which was principally secreted into the culture
medium, as compared to controls kept normoxic or
hypoxic throughout [110]. Further, conditioned medium
from villous tissues subjected to H/R caused growth dis-
turbance and expression of E-selectin on cultured human
umbilical vein endothelial cells (HUVECs). It was found
that TNF-α in the conditioned medium contributed, at
least in part, to the activation of HUVECs.
Three main conclusions can be drawn from these
findings. Firstly, as noted before, a variable degree of
oxidative stress is present in the normal term placenta
before the onset of labor. Secondly, reoxygenation at
5% O2/90% N2/5% CO2 is just as efficient at gener-
ating oxidative stress as is reoxygenation at air/5%
CO2, which could arguably be considered a hyperoxic
challenge. The mean oxygen tension measured in the
intervillous space at term in vivo is approximately
30–45 mmHg [111,112], and so 5% O2 is within the
physiologic range. Thirdly, although there is clearly
overlap in the effects caused by the two insults, H/R
appears to be a much more potent stimulus of all the
changes than hypoxia alone. It should be noted that
the level of hypoxia used to induce these changes was
almost certainly incompatible with survival of a fetus
in vivo, and so this would suggest that H/R may be the
more physiologic insult.
Overview and Conclusion
The cause of increased placental oxidative stress in
preeclampsia remains unclear. There is no doubt that
both hypoxia and H/R lead to ROS production, and
so a large overlap exists between the pathologies that
the two insults can create. Both may also arise from
the same underlying problem of impaired conversion
of the spiral arteries, and so are difficult to separate
on a clinical basis. We must therefore speculate as to
which is the more likely scenario. From the evidence
presented in the literature, it can be seen that there is 
a plausible basis from which to assume that blood
flow in the intervillous space will be intermittent. It is
also well established that in many cases of late onset
preeclampsia, fetal and placental weights are normal.
This argues against chronic hypoxia being the causative
agent, as does the constancy of energy levels within the
placental tissues. Furthermore, our work has demon-
strated that of the two insults, H/R is by far the most
potent in inducing the placental changes seen in pre-
eclampsia. Although hypoxia can induce some of the
same changes, the levels required are not compatible
with normal fetal and placental weights, and with nor-
mal placental energy levels. Finally, the demonstration
of increased XO expression in the preeclamptic pla-
centa provides arguably the strongest evidence for the
potential of a H/R injury. All these points reinforce the
general concept that at physiologic levels, it is fluctua-
tions in the oxygen concentration that are more impor-
tant than the absolute level.
The most credible strength of the “H/R injury” theory
lies in its ability to explain why preeclampsia can occur
in both women with abnormal and normal placenta-
tion. From the evidence presented here, it is clear that
intermittent perfusion of the intervillous space occurs
in all normal pregnancies, and may provide the basis for
the baseline level of oxidative stress seen in normal pla-
centas. The variability in blood flow will likely increase
towards term as the uterine contractions become
more frequent and stronger, and may also be increased
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by endogenous or exogenous vasostimulants. Oxygen
concentrations in the intervillous space will therefore
fluctuate on a regional basis, although overall oxy-
genation to the fetus is preserved, allowing for normal
growth. The magnitude of these fluctuations in oxygen
concentration will depend on the severity and dura-
tion of the vasoconstriction, but will generally tend to
increase towards term as fetal oxygen extraction rises.
Increasing fetal extraction will mean that deoxygena-
tion of the intervillous space blood occurs more rap-
idly and more completely during the periods of stasis.
When the oxygen returns as blood flow is reestablished,
a H/R type insult will occur, the severity of which will
depend on the degree of deoxygenation and the level
of tissue antioxidant defences. It is likely to be mild in
early to mid pregnancy, but will increase towards term
as the balance between oxygen delivery to the intervil-
lous space and fetal extraction becomes less favorable,
resulting in placental oxidative stress.
The effects of the reduced trophoblast invasion
associated with complicated pregnancies can easily be
superimposed on this basic model. Reduced invasion
will leave the spiral arteries vasoreactive, and thus
more likely to undergo spontaneous transient vaso-
constriction. They will thus be more responsive to
endogenous and exogenous vasoactive stimuli. Partial
obliteration of their lumens by atherotic changes will
also impair flow, and may exacerbate the effects of uter-
ine contractions by reducing the closing dimensions.
Hence, the magnitude of oxygen fluctuations for a
given gestational age will be increased, so increasing
the oxidative stress within the placenta. Excessive pro-
duction of inflammatory cytokines, deportation of
apoptotic microvillous placental fragments, activation
of maternal leukocytes and platelets, or depletion of
NO production may then cause or contribute to the
maternal endothelial response. The degree of the oxida-
tive stress will likely reflect the extent of the maternal
vascular pathology. If the latter is sufficiently severe,
then some chronic impairment of placental perfusion
might also be expected, leading to associated fetal
growth restriction. Such cases will probably display
clinical symptoms earlier in pregnancy due to the
increased placental oxidative stress, and will represent
early onset of preeclampsia.
On this basis, there will be a complete spectrum of
placental changes among the normal, the late onset
and the early onset preeclamptic states. This view fits
with the spectrum of vascular changes that has been
reported in the spiral arteries [23]. The continuum
theory is also supported by the clinical observation
that there is a high degree of overlap between the 
values of almost any parameter in preeclampsia and
normal pregnancy [12]. How the placental changes
induce the syndrome is beyond the scope of this work,
but broadly preeclampsia may be the result of exces-
sive homeostatic signals or toxic products arising from
the placenta, or an abnormally sensitive maternal
response to physiologic levels of these same signals
and products [8]. However, viewing the syndrome as a
continuum of H/R insults provides new insight into
the pathophysiology of pregnancy that may hopefully
lead to improved clinical interventions.
Acknowledgments
This work was partly supported by the National Science
Council, Taiwan (grant no. NSC94-2314-B182A-142).
Dr Tai-Ho Hung is supported by Chang Gung Memorial
Hospital as a Physician Scientist.
References
1. Lindheimer MD, Roberts JM, Chesley L. Introduction, his-
tory, controversies and definitions. In: Lindheimer MD,
Roberts JM, Cunningham FG, eds. Chesley’s Hypertensive
Disorders in Pregnancy, 2nd edition. Stamford, Connecticut:
Appleton & Lange, 1999:3–41.
2. Carroli G, Duley L, Belizan JM, Villar J. Calcium supplemen-
tation during pregnancy: a systematic review of randomised
controlled trials. Br J Obstet Gynaecol 1994;101:753–8.
3. Lee CJ, Hsieh TT, Chiu TH, Chen KC, Lo LM, Hung TH. Risk
factors for pre-eclampsia in an Asian population. Int J
Gynaecol Obstet 2000;70:327–33.
4. Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R.
Epidemiology of preeclampsia and eclampsia in the United
States, 1979–1986. Am J Obstet Gynecol 1990;163:460–5.
5. Sibai BM, Caritis SN, Thom E, et al. Prevention of pre-
eclampsia with low-dose aspirin in healthy, nulliparous
pregnant women. The National Institute of Child Health
and Human Development Network of Maternal-Fetal
Medicine Units. N Engl J Med 1993;329:1213–8.
6. Meis PJ, Goldenberg RL, Mercer BM, et al. The preterm 
prediction study: risk factors for indicated preterm births.
Maternal-Fetal Medicine Units Network of the National
Institute of Child Health and Human Development. Am J
Obstet Gynecol 1998;178:562–7.
7. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA,
McLaughlin MK. Preeclampsia: an endothelial cell disorder.
Am J Obstet Gynecol 1989;161:1200–4.
8. Roberts JM, Lain KY. Recent insights into the pathogenesis
of pre-eclampsia. Placenta 2002;23:359–72.
9. Roberts JM, Gammill HS. Preeclampsia: recent insights.
Hypertension 2005;46:1243–9.
10. Taylor RN, Roberts JM. Endothelial cell dysfunction. In:
Lindheimer MD, Roberts JM, Cunningham FG, eds. Chesley’s
Hypertensive Disorders in Pregnancy, 2nd edition. Stamford,
Connecticut: Appleton & Lange, 1999:395–429.
Taiwanese J Obstet Gynecol • September 2006 • Vol 45 • No 3 197
Hypoxia and Reoxygenation
11. Ness RB, Roberts JM. Heterogeneous causes constituting
the single syndrome of preeclampsia: a hypothesis and its
implications. Am J Obstet Gynecol 1996;175:1365–70.
12. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an exces-
sive maternal inflammatory response to pregnancy. Am J
Obstet Gynecol 1999;180:499–506.
13. Sacks GP, Studena K, Sargent K, Redman CW. Normal
pregnancy and preeclampsia both produce inflammatory
changes in peripheral blood leukocytes akin to those of
sepsis. Am J Obstet Gynecol 1998;179:80–6.
14. Redman CW, Sargent IL. Placental debris, oxidative stress
and pre-eclampsia. Placenta 2000;21:597–602.
15. Redman CW, Sargent IL. Latest advances in understanding
preeclampsia. Science 2005;308:1592–4.
16. Page EW. The relation between hydatid moles, relative
ischaemia of the gravid uterus, and the placental origin of
eclampsia. Am J Obstet Gynecol 1939;37:291–3.
17. Chun D, Braga C, Chow C, Lok L. Clinical observations on
some aspects of hydatidiform moles. J Obstet Gynaecol Br
Commonw 1964;71:180–4.
18. Piering WF, Garancis JG, Becker CG, Beres JA, Lemann J, Jr.
Preeclampsia related to a functioning extrauterine pla-
centa: report of a case and 25-year follow-up. Am J Kidney
Dis 1993;21:310–3.
19. Shembrey MA, Noble AD. An instructive case of abdominal
pregnancy. Aust N Z J Obstet Gynaecol 1995;35:220–1.
20. Leveno KJ, Cunningham FG. Management of preeclampsia.
In: Lindheimer MD, Roberts JM, Cunningham FG, eds.
Chesley’s Hypertensive Disorders in Pregnancy, 2nd edition.
Stamford, Connecticut: Appleton & Lange, 1999:543–80.
21. Brosens IA. The utero-placental vessels at term—the distri-
bution and extent of physiological changes. Trophoblast Res
1988;3:61–7.
22. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate
maternal vascular response to placentation in pregnancies
complicated by pre-eclampsia and by small-for-gestational
age infants. Br J Obstet Gynaecol 1986;93:1049–59.
23. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van
Asshe A. A study of placental bed spiral arteries and tro-
phoblast invasion in normal and severe pre-eclamptic preg-
nancies. Br J Obstet Gynaecol 1994;101:669–74.
24. Brosens IA, Robertson WB, Dixon HG. The role of the spi-
ral arteries in the pathogenesis of preeclampsia. Obstet
Gynecol Annu 1972;1:177–91.
25. Chien PF, Arnott N, Gordon A, Owen P, Khan KS. How use-
ful is uterine artery Doppler flow velocimetry in the predic-
tion of pre-eclampsia, intrauterine growth retardation and
perinatal death? An overview. BJOG 2000;107:196–208.
26. Pijnenborg R, Anthony J, Davey DA, et al. Placental bed spi-
ral arteries in the hypertensive disorders of pregnancy. Br J
Obstet Gynaecol 1991;98:648–55.
27. Khalil RA, Granger JP. Vascular mechanisms of increased
arterial pressure in preeclampsia: lessons from animal mod-
els. Am J Physiol Regul Integr Comp Physiol 2002;283:R29–45.
28. Lang U, Baker RS, Khoury J, Clark KE. Effects of chronic reduc-
tion in uterine blood flow on fetal and placental growth in the
sheep. Am J Physiol Regul Integr Comp Physiol 2000;279:R53–9.
29. Bloxam DL, Bullen BE, Walters BN, Lao TT. Placental gly-
colysis and energy metabolism in preeclampsia. Am J Obstet
Gynecol 1987;157:97–101.
30. Xiong X, Demianczuk NN, Buekens P, Saunders LD.
Association of preeclampsia with high birth weight for age.
Am J Obstet Gynecol 2000;183:148–55.
31. Arias F, Rodriquez L, Rayne SC, Kraus FT. Maternal placen-
tal vasculopathy and infection: two distinct subgroups
among patients with preterm labor and preterm ruptured
membranes. Am J Obstet Gynecol 1993;168:585–91.
32. Kim YM, Chaiworapongsa T, Gomez R, et al. Failure of
physiologic transformation of the spiral arteries in the pla-
cental bed in preterm premature rupture of membranes.
Am J Obstet Gynecol 2002;187:1137–42.
33. Espinoza J, Sebire NJ, McAuliffe F, Krampl E, Nicolaides
KH. Placental villus morphology in relation to maternal
hypoxia at high altitude. Placenta 2001;22:606–8.
34. Reshetnikova OS, Burton GJ, Milovanov AP. Effects of
hypobaric hypoxia on the fetoplacental unit: the morpho-
metric diffusing capacity of the villous membrane at high
altitude. Am J Obstet Gynecol 1994;171:1560–5.
35. Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN,
Burton GJ. Onset of maternal arterial blood flow and pla-
cental oxidative stress. A possible factor in human early preg-
nancy failure. Am J Pathol 2000;157:2111–22.
36. Watson AL, Skepper JN, Jauniaux E, Burton GJ. Susceptibility
of human placental syncytiotrophoblastic mitochondria 
to oxygen-mediated damage in relation to gestational age. 
J Clin Endocrinol Metab 1998;83:1697–705.
37. Martin CBJ, McGaughey HSJ, Kaiser IH, Donner MW,
Ramsey EM. Intermittent functioning of the uteroplacental
arteries. Am J Obstet Gynecol 1964;90:819–23.
38. Lees MH, Hill JD, Ochsner AJ III, Thomas CL, Novy MJ.
Maternal placental and myometrial blood flow of the rhe-
sus monkey during uterine contractions. Am J Obstet Gynecol
1971;110:68–81.
39. Ramsey EM, Corner GW Jr, Donner MW. Serial and cinera-
dioangiographic visualization of maternal circulation in the
primate (hemochorial) placenta. Am J Obstet Gynecol 1963;
86:213–25.
40. Borell U, Fernstrom I, Ohlson L, Wiqvist N. An arteriographic
study of the blood flow through the uterus and the placenta
at midpregnancy. Acta Obstet Gynecol Scand 1965;44:22–31.
41. Wigglesworth JS. Vascular anatomy of the human placenta
and its significance for placental pathology. J Obstet Gynaecol
Br Commonw 1969;76:979–89.
42. Carter AM. Placental oxygen consumption. Part I: in vivo
studies—a review. Placenta 2000;21:S31–7.
43. Schachter M, Foulds S. Free radicals and the xanthine oxi-
dase pathway. In: Grace PA, Mathie RT, eds. Ischaemia-
Reperfusion Injury. London: Blackwell Science, 1999:137–47.
44. Halliwell B, Gutteridge MC. Oxygen is a toxic gas—an intro-
duction to oxygen toxicity and reactive oxygen species. In:
Halliwell B, Gutteridge MC, eds. Free Radicals in Biology and
Medicine, 3rd edition. Oxford: Oxford University Press, 1999:
1–35.
45. Du G, Mouithys-Mickalad A, Sluse FE. Generation of super-
oxide anion by mitochondria and impairment of their func-
tions during anoxia and reoxygenation in vitro. Free Radic 
Biol Med 1998;25:1066–74.
46. Turrens JF. Superoxide production by the mitochondrial
respiratory chain. Biosci Rep 1997;17:3–8.
Taiwanese J Obstet Gynecol • September 2006 • Vol 45 • No 3198
T.H. Hung, G.J. Burton
47. Granger DN, Korthuis RJ. Physiologic mechanisms of postis-
chemic tissue injury. Annu Rev Physiol 1995;57:311–32.
48. Halliwell B, Gutteridge MC. Antioxidant defences. In:
Halliwell B, Gutteridge MC, eds. Free Radicals in Biology and
Medicine, 3rd edition. Oxford: Oxford University Press, 1999:
105–245.
49. Halliwell B, Gutteridge MC. Oxidative stress: adaptation,
damage, repair and death. In: Halliwell B, Gutteridge MC,
eds. Free Radicals in Biology and Medicine, 3rd edition. Oxford:
Oxford University Press, 1999:246–350.
50. Martindale JL, Holbrook NJ. Cellular response to oxidative
stress: signaling for suicide and survival. J Cell Physiol 2002;
192:1–15.
51. Li C, Jackson RM. Reactive species mechanisms of cellular
hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 2002;
282:C227–41.
52. Berridge MJ, Lipp P, Bootman MD. The versatility and uni-
versality of calcium signalling. Nat Rev Mol Cell Biol 2000;
1:11–21.
53. Crompton M. Mitochondrial intermembrane junctional com-
plexes and their role in cell death. J Physiol 2000;529:11–21.
54. Ferri KF, Kroemer G. Organelle-specific initiation of cell
death pathways. Nat Cell Biol 2001;3:E255–63.
55. Kowaltowski AJ, Castilho RF, Vercesi AE. Mitochondrial per-
meability transition and oxidative stress. FEBS Lett 2001;
495:12–5.
56. Kristal BS, Park BK, Yu BP. 4-Hydroxyhexenal is a potent
inducer of the mitochondrial permeability transition. J Biol
Chem 1996;271:6033–8.
57. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An
overview of cell death. Am J Pathol 1995;146:3–15.
58. Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P.
Intracellular adenosine triphosphate (ATP) concentration:
a switch in the decision between apoptosis and necrosis. J
Exp Med 1997;185:1481–6.
59. Carden DL, Granger DN. Pathophysiology of ischaemia-
reperfusion injury. J Pathol 2000;190:255–66.
60. Panes J, Granger DN. Neutrophils and adhesion molecules.
In: Grace PA, Mathie RT, eds. Ischaemia-Reperfusion Injury.
Oxford: Blackwell Science Ltd, 1999:262–80.
61. Neary P, Redmond HP. Ischaemia-reperfusion injury and
systemic inflammatory response syndrome. In: Grace PA,
Mathie RT, eds. Ischaemia-Reperfusion Injury. London: Blackwell
Science, 1999:123–34.
62. Many A, Westerhausen-Larson A, Kanbour-Shakir A,
Roberts JM. Xanthine oxidase/dehydrogenase is present in
human placenta. Placenta 1996;17:361–5.
63. Many A, Roberts JM. Increased xanthine oxidase during
labour—implications for oxidative stress. Placenta 1997;18:
725–6.
64. O’Connor MC, Harkness RA, Simmonds RJ, Hytten FE. The
measurement of hypoxanthine, xanthine, inosine and uridine
in umbilical cord blood and fetal scalp blood samples as a
measure of fetal hypoxia. Br J Obstet Gynaecol 1981;88:381–90.
65. Many A, Hubel CA, Fisher SJ, Roberts JM, Zhou Y. Invasive
cytotrophoblasts manifest evidence of oxidative stress in
preeclampsia. Am J Pathol 2000;156:321–31.
66. Many A, Hubel CA, Roberts JM. Hyperuricemia and xan-
thine oxidase in preeclampsia, revisited. Am J Obstet Gynecol
1996;174:288–91.
67. Wang Y, Walsh SW. Placental mitochondria as a source of
oxidative stress in pre-eclampsia. Placenta 1998;19:581–6.
68. Roberts JM, Hubel CA. Is oxidative stress the link in the
two-stage model of pre-eclampsia? Lancet 1999;354:788–9.
69. Rogers BB, Bloom SL, Leveno KJ. Atherosis revisited: cur-
rent concepts on the pathophysiology of implantation site
disorders. Obstet Gynecol Surv 1999;54:189–95.
70. Hubel CA. Oxidative stress in the pathogenesis of pre-
eclampsia. Proc Soc Exp Biol Med 1999;222:222–35.
71. Gupta S, Agarwal A, Sharma RK. The role of placental oxida-
tive stress and lipid peroxidation in preeclampsia. Obstet
Gynecol Surv 2005;60:807–16.
72. Staff AC, Halvorsen B, Ranheim T, Henriksen T. Elevated
level of free 8-iso-prostaglandin F2alpha in the decidua
basalis of women with preeclampsia. Am J Obstet Gynecol
1999;181:1211–5.
73. Staff AC, Ranheim T, Khoury J, Henriksen T. Increased con-
tents of phospholipids, cholesterol, and lipid peroxides in
decidua basalis in women with preeclampsia. Am J Obstet
Gynecol 1999;180:587–92.
74. Walsh SW, Vaughan JE, Wang Y, Roberts LJ. Placental iso-
prostane is significantly increased in preeclampsia. FASEB J
2000;14:1289–96.
75. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF,
Roberts LJ. A series of prostaglandin F2-like compounds
are produced in vivo in humans by a non-cyclooxygenase,
free radical-catalyzed mechanism. Proc Natl Acad Sci USA
1990;87:9383–7.
76. Kwek K, Read MA, Khong TY, Bisits AT, Walters WA.
Vasoactive effects of 8-epi-prostaglandin F(2alpha) in iso-
lated human placental conduit and resistance blood vessels
in vitro. Placenta 2001;22:526–33.
77. Minuz P, Gaino S, Zuliani V, et al. Functional role of p38 mito-
gen activated protein kinase in platelet activation induced
by a thromboxane A2 analogue and by 8-iso-prostaglandin
F2alpha. Thromb Haemost 2002;87:888–98.
78. Yura T, Fukunaga M, Khan R, Nassar GN, Badr KF,
Montero A. Free-radical-generated F2-isoprostane stimulates
cell proliferation and endothelin-1 expression on endothelial
cells. Kidney Int 1999;56:471–8.
79. Walsh SW, Wang Y. Deficient glutathione peroxidase activ-
ity in preeclampsia is associated with increased placental
production of thromboxane and lipid peroxides. Am J
Obstet Gynecol 1993;169:1456–61.
80. Walsh SW, Wang Y. Trophoblast and placental villous core
production of lipid peroxides, thromboxane, and prostacy-
clin in preeclampsia. J Clin Endocrinol Metab 1995;80:1888–93.
81. Myatt L, Brockman DE, Eis AL, Pollock JS. Immuno-
histochemical localization of nitric oxide synthase in the
human placenta. Placenta 1993;14:487–95.
82. Myatt L, Eis AL, Brockman DE, Kossenjans W, Greer I, Lyall
F. Inducible (type II) nitric oxide synthase in human placen-
tal villous tissue of normotensive, pre-eclamptic and intra-
uterine growth-restricted pregnancies. Placenta 1997;18:
261–8.
83. Huie RE, Padmaja S. The reaction of NO with superoxide.
Free Radic Res Commun 1993;18:195–9.
84. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and
peroxynitrite: the good, the bad, and ugly. Am J Physiol
1996;271:C1424–37.
Taiwanese J Obstet Gynecol • September 2006 • Vol 45 • No 3 199
Hypoxia and Reoxygenation
85. Depre C, Havaux X, Renkin J, Vanoverschelde JL, Wijns W.
Expression of inducible nitric oxide synthase in human coro-
nary atherosclerotic plaque. Cardiovasc Res 1999;41:465–72.
86. Myatt L, Rosenfield RB, Eis AL, Brockman DE, Greer I,
Lyall F. Nitrotyrosine residues in placenta. Evidence of 
peroxynitrite formation and action. Hypertension 1996;28:
488–93.
87. Poranen AK, Ekblad U, Uotila P, Ahotupa M. Lipid peroxi-
dation and antioxidants in normal and pre-eclamptic preg-
nancies. Placenta 1996;17:401–5.
88. Wang Y, Walsh SW. Antioxidant activities and mRNA
expression of superoxide dismutase, catalase, and gluta-
thione peroxidase in normal and preeclamptic placentas. 
J Soc Gynecol Investig 1996;3:179–84.
89. Green DR. Apoptotic pathways: paper wraps stone blunts
scissors. Cell 2000;102:1–4.
90. Smith SC, Baker PN, Symonds EM. Placental apoptosis in
normal human pregnancy. Am J Obstet Gynecol 1997;177:
57–65.
91. Huppertz B, Frank HG, Reister F, Kingdom J, Korr H,
Kaufmann P. Apoptosis cascade progresses during turnover
of human trophoblast: analysis of villous cytotrophoblast
and syncytial fragments in vitro. Lab Invest 1999;79:1687–702.
92. Levy R, Nelson DM. To be, or not to be, that is the question.
Apoptosis in human trophoblast. Placenta 2000;21:1–13.
93. Leung DN, Smith SC, To KF, Sahota DS, Baker PN.
Increased placental apoptosis in pregnancies complicated
by preeclampsia. Am J Obstet Gynecol 2001;184:1249–50.
94. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA.
Placental apoptosis in preeclampsia. Obstet Gynecol 2000;
96:271–6.
95. Conrad KP, Benyo DF. Placental cytokines and the pathogen-
esis of preeclampsia. Am J Reprod Immunol 1997;37:240–9.
96. Dekker GA, Sibai BM. Etiology and pathogenesis of
preeclampsia: current concepts. Am J Obstet Gynecol 1998;
179:1359–75.
97. Taylor RN. Review: immunobiology of preeclampsia. Am J
Reprod Immunol 1997;37:79–86.
98. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil
RA. Pathophysiology of hypertension during preeclampsia
linking placental ischemia with endothelial dysfunction.
Hypertension 2001;38:718–22.
99. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, et al.
Expression of the placental cytokines tumor necrosis factor
alpha, interleukin 1beta, and interleukin 10 is increased in
preeclampsia. Am J Obstet Gynecol 1999;181:915–20.
100. Wang Y, Walsh SW. TNF alpha concentrations and mRNA
expression are increased in preeclamptic placentas. J Reprod
Immunol 1996;32:157–69.
101. Hajjar KA, Hajjar DP, Silverstein RL, Nachman RL. Tumor
necrosis factor-mediated release of platelet-derived growth
factor from cultured endothelial cells. J Exp Med 1987;
166:235–45.
102. Marsden PA, Brenner BM. Transcriptional regulation of
the endothelin-1 gene by TNF-alpha. Am J Physiol 1992;262:
C854–61.
103. van Hinsbergh VW, Kooistra T, van den Berg EA, Princen
HM, Fiers W, Emeis JJ. Tumor necrosis factor increases the
production of plasminogen activator inhibitor in human
endothelial cells in vitro and in rats in vivo. Blood 1988;
72:1467–73.
104. Alexander BT, Cockrell KL, Massey MB, Bennett WA,
Granger JP. Tumor necrosis factor-alpha-induced hyper-
tension in pregnant rats results in decreased renal neu-
ronal nitric oxide synthase expression. Am J Hypertens 2002;
15:170–5.
105. Giardina JB, Green GM, Cockrell KL, Granger JP, Khalil
RA. TNF-α enhances contraction and inhibits endothelial
NO-cGMP relaxation in systemic vessels of pregnant rats.
Am J Physiol Regul Integr Comp Physiol 2002;283:R130–43.
106. Hung T, Skepper JN, Burton GJ. In vitro ischemia-reperfusion
injury in term human placenta as a model for oxidative
stress in pathological pregnancies. Am J Pathol 2001;159:
1031–43.
107. Shibata E, Ejima K, Nanri H, et al. Enhanced protein levels
of protein thiol/disulphide oxidoreductases in placentae
from pre-eclamptic subjects. Placenta 2001;22:566–72.
108. Morikawa S, Kurauchi O, Tanaka M, et al. Increased mito-
chondrial damage by lipid peroxidation in trophoblast cells
of preeclamptic placentas. Biochem Mol Biol Int 1997;41:
767–75.
109. Hung TH, Skepper JN, Charnock-Jones DS, Burton GJ.
Hypoxia-reoxygenation: a potent inducer of apoptotic
changes in the human placenta and possible etiological
factor in preeclampsia. Circ Res 2002;90:1274–81.
110. Hung TH, Charnock-Jones DS, Skepper JN, Burton GJ.
Secretion of tumor necrosis factor-{alpha} from human
placental tissues induced by hypoxia-reoxygenation causes
endothelial cell activation in vitro: a potential mediator of
the inflammatory response in preeclampsia. Am J Pathol
2004;164:1049–61.
111. Fujikura T, Yoshida J. Blood gas analysis of placental and
uterine blood during cesarean delivery. Obstet Gynecol 1996;
87:133–6.
112. Soothill PW, Nicolaides KH, Rodeck CH, Campbell S.
Effect of gestational age on fetal and intervillous blood gas
and acid-base values in human pregnancy. Fetal Ther 1986;
1:168–75.
Taiwanese J Obstet Gynecol • September 2006 • Vol 45 • No 3200
T.H. Hung, G.J. Burton
